Characteristics of Early Paget's Disease in SQSTM1 Mutation Carriers: Baseline Analysis of the ZiPP Study Cohort

Owen Cronin, Deepak Subedi, Laura Forsyth, Kirsteen Goodman, Steff C. Lewis, Catriona Keerie, Allan Walker, Mary Porteous, Roseanne Cetnarskyj, Lakshminarayan R. Ranganath, Peter L. Selby, Geeta Hampson, Rama Chandra, Shu Ho, Jon H. Tobias, Steven A. Young-Min, Malachi J. McKenna, Rachel K. Crowley, William D. Fraser, Jonathan TangLuigi Gennari, Rannuccio Nuti, Maria Luisa Brandi, Javier del Pino-Montes, Jean Pierre Devogelaer, Anne Durnez, Giovanni Carlo Isaia, Marco Di Stefano, Josep Blanch Rubio, Nuria Guanabens, Markus J. Seibel, John P. Walsh, Mark A. Kotowicz, Geoffrey C. Nicholson, Emma L. Duncan, Gabor Major, Anne Horne, Nigel L. Gilchrist, Stuart H. Ralston

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Mutations in SQSTM1 are strongly associated with Paget's disease of bone (PDB), but little is known about the clinical characteristics of those with early disease. Radionuclide bone scans, biochemical markers of bone turnover, and clinical characteristics were analyzed in SQSTM1 mutation carriers who took part in the Zoledronic acid in the Prevention of Paget's disease (ZiPP) study. We studied 222 individuals, of whom 54.9% were female, with mean ± SE age of 50.1 ± 0.6 years. Twelve SQSTM1 mutations were observed, including p.Pro392Leu, which was present in 141 of 222 (63.5%) subjects. Bone scan examination revealed evidence of PDB in 20 subjects (9.0%), ten of whom (50%) had a single affected site. Participants with lesions were older than those without lesions but the difference was not significant (53.6 ± 9.1 versus 49.8 ± 8.9; p =.07). The mean age of participants with lesions was not significantly different from the age at which their parents were diagnosed with PDB (55 years versus 59 years, p =.17). All individuals with lesions were asymptomatic. Serum concentrations of total alkaline phosphatase (ALP) normalized to the upper limit of normal in each center were higher in those with lesions (0.75 ± 0.69 versus 0.42 ± 0.29 arbitary units; p <.0001). Similar findings were observed for other biochemical markers of bone turnover, but the sensitivity of ALP and other markers in detecting lesions was poor. Asymptomatic PDB is present in about 9% of SQSTM1 mutation carriers by the fifth decade. Further follow-up of this cohort will provide important information on the natural history of early PDB and its response to treatment.

Original languageEnglish
Pages (from-to)1246-1252
Number of pages7
JournalJournal of Bone and Mineral Research
Volume35
Issue number7
DOIs
Publication statusPublished - 1 Jul 2020

Fingerprint Dive into the research topics of 'Characteristics of Early Paget's Disease in SQSTM1 Mutation Carriers: Baseline Analysis of the ZiPP Study Cohort'. Together they form a unique fingerprint.

  • Cite this

    Cronin, O., Subedi, D., Forsyth, L., Goodman, K., Lewis, S. C., Keerie, C., Walker, A., Porteous, M., Cetnarskyj, R., Ranganath, L. R., Selby, P. L., Hampson, G., Chandra, R., Ho, S., Tobias, J. H., Young-Min, S. A., McKenna, M. J., Crowley, R. K., Fraser, W. D., ... Ralston, S. H. (2020). Characteristics of Early Paget's Disease in SQSTM1 Mutation Carriers: Baseline Analysis of the ZiPP Study Cohort. Journal of Bone and Mineral Research, 35(7), 1246-1252. https://doi.org/10.1002/jbmr.4007